The Boston Globe reports on a survey showing that in aggregate, the amount of money drug companies are paying Massachusetts doctors for product endorsements is declining, in indicator that physicians may be distancing themselves from the pharmaceutical industry and the lucrative deals it offers.
“In 2009 and the first half of 2010, doctors and researchers affiliated with Harvard Medical School – a brand prized by pharmaceutical companies as a powerful tool in promoting drugs – collected a large portion of the speaking fees paid by drug companies, according to a similar analysis the news organizations conducted a year ago. But new data for 2010 and the first quarter of 2011 reveal that many Harvard doctors have stopped giving promotional talks as new limits have been phased in.
‘There’s just a growing recognition, at least for academic physicians, that participation in speakers bureaus is inappropriate,’ said Eric Campbell, a health care policy professor at Harvard.”
Read the story here.